Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.
暂无分享,去创建一个
Brenda W Gillespie | M. Mayes | B. Gillespie | J. Beebe-Dimmer | D. Schottenfeld | T. Laing | David Schottenfeld | Timothy J Laing | Maureen D Mayes | Jennifer Beebe-Dimmer | James V Lacey | Brenda Cooper | B. Cooper | J. V. Lacey | J. Lacey | Brenda C. Cooper
[1] V W Sidel,et al. Capture-recapture methods for assessing the completeness of case ascertainment when using multiple information sources. , 1974, Journal of chronic diseases.
[2] K. Davis,et al. Systemic sclerosis prevalence and mortality in Sydney 1974-88. , 1999, Australian and New Zealand journal of medicine.
[3] J. D. McNeil,et al. South Australian scleroderma register: Analysis of deceased patients , 1998, Pathology.
[4] James F. Fries,et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.
[5] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[6] J. Reveille,et al. HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). , 1999, Tissue antigens.
[7] Y. Ikeda,et al. Initial predictors of survival in patients with systemic sclerosis (scleroderma). , 1992, The Keio journal of medicine.
[8] A. Wiik,et al. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. , 2001, The Journal of rheumatology.
[9] A. Silman. Scleroderma--demographics and survival. , 1997, The Journal of rheumatology. Supplement.
[10] É. Rich,et al. Predicting Mortality in Systemic Sclerosis: Analysis of a Cohort of 309 French Canadian Patients with Emphasis on Features at Diagnosis as Predictive Factors for Survival , 2002, Medicine.
[11] Jerald F. Lawless,et al. Statistical Models and Methods for Lifetime Data. , 1983 .
[12] T. Medsger,et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.
[13] A. Masi,et al. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. , 1971, Annals of internal medicine.
[14] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[15] W. Hauser,et al. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. , 1969, Mayo Clinic proceedings.
[16] J. Reveille,et al. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. , 1996, Arthritis and rheumatism.
[17] M. Mayes,et al. Racial differences in scleroderma among women in Michigan. , 1997, Arthritis and rheumatism.
[18] J. Reveille,et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. , 2001, Seminars in arthritis and rheumatism.
[19] M. Weinrich,et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. , 1989, Arthritis and rheumatism.
[20] A. Silman. Mortality from scleroderma in England and Wales 1968-1985. , 1991, Annals of the rheumatic diseases.
[21] D. Buskila,et al. Mortality in systemic sclerosis (scleroderma). , 1992, The Quarterly journal of medicine.
[22] S. Bombardieri,et al. Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients , 2002, Medicine.
[23] L. Elveback,et al. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. , 1985, Mayo Clinic proceedings.
[24] R R Regal,et al. The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. , 1992, American journal of epidemiology.
[25] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[26] A. Masi,et al. The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. , 1978, Journal of chronic diseases.
[27] K. Steinsson,et al. Systemic sclerosis in Iceland. A nationwide epidemiological study. , 1994, Annals of the rheumatic diseases.
[28] T. Medsger,et al. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. , 1997, Arthritis and rheumatism.
[29] R R Regal,et al. Accuracy of alternative approaches to capture-recapture estimates of disease frequency: internal validity analysis of data from five sources. , 2000, American journal of epidemiology.
[30] J. Walker,et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance , 2001, Internal medicine journal.
[31] D. Bloch,et al. Predictors of survival in systemic sclerosis (scleroderma). , 1991, Arthritis and rheumatism.
[32] A. Silman,et al. An epidemiological study of scleroderma in the West Midlands. , 1988, British journal of rheumatology.
[33] M. Mayes,et al. The design of a population-based case-control study of systemic sclerosis (scleroderma): commentary on the University of Michigan study. , 1995, Journal of clinical epidemiology.
[34] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.
[35] K. Takehara,et al. Epidemiological study of patients with systemic sclerosis in Tokyo , 2004, Archives of Dermatological Research.
[36] G. Littlejohn,et al. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. , 1988, The Journal of rheumatology.
[37] A. Masi,et al. Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. , 1973, Journal of chronic diseases.
[38] A. Masi,et al. Epidemiology of systemic sclerosis (scleroderma). , 1971, Annals of internal medicine.